首页> 美国卫生研究院文献>Frontiers in Immunology >A Novel Quantitative Fluorescent Reporter Assay for RAG Targets and RAG Activity
【2h】

A Novel Quantitative Fluorescent Reporter Assay for RAG Targets and RAG Activity

机译:RAG靶标和RAG活性的新型定量荧光报告基因测定。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recombination-Activating Genes (RAG) 1 and 2 form the site specific recombinase that mediates V(D)J recombination, a process of DNA editing required for lymphocyte development and responsible for their diverse repertoire of antigen receptors. Mistargeted RAG activity associates with genome alteration and is responsible for various lymphoid tumors. Moreover several non-lymphoid tumors express RAG ectopically. A practical and powerful tool to perform quantitative assessment of RAG activity and to score putative RAG-Recognition signal sequences (RSS) is required in the fields of immunology, oncology, gene therapy, and development. Here we report the detailed characterization of a novel fluorescence-based reporter of RAG activity, named GFPi, a tool that allows measuring recombination efficiency (RE) by simple flow cytometry analysis. GFPi can be produced both as a plasmid for transient transfection experiments in cell lines or as a retrovirus for stable integration in the genome, thus supporting ex vivo and in vivo studies. The GFPi assay faithfully quantified endogenous and ectopic RAG activity as tested in genetically modified fibroblasts, tumor derived cell lines, developing pre-B cells, and hematopoietic cells. The GFPi assay also successfully ranked the RE of various RSS pairs, including bona fide RSS associated with V(D)J segments, artificial consensus sequences modified or not at specific nucleotides known to affect their efficiencies, or cryptic RSS involved in RAG-dependent activation of oncogenes. Our work validates the GFPi reporter as a practical quantitative tool for the study of RAG activity and RSS efficiencies. It should turn useful for the study of RAG-mediated V(D)J and aberrant rearrangements, lineage commitment, and vertebrate evolution.
机译:重组激活基因(RAG)1和2形成了位点特异性重组酶,介导V(D)J重组,这是淋巴细胞发育所需的DNA编辑过程,并负责其不同的抗原受体组成。定向不正确的RAG活性与基因组改变有关,并导致各种淋巴样肿瘤。此外,一些非淋巴样肿瘤异位表达RAG。在免疫学,肿瘤学,基因治疗和开发领域,需要一种实用而强大的工具来对RAG活性进行定量评估并为假定的RAG识别信号序列(RSS)评分。在这里,我们报告了一种新型的基于荧光的RAG活性报告基因GFPi的详细特征,该工具名为GFPi,该工具可通过简单的流式细胞仪分析来测量重组效率(RE)。 GFPi既可以作为在细胞系中进行瞬时转染实验的质粒,也可以作为逆转录病毒来生产,以在基因组中稳定整合,从而支持离体和体内研究。 GFPi分析如实地定量了内源和异位RAG活性,如在基因修饰的成纤维细胞,肿瘤衍生的细胞系,发育中的前B细胞和造血细胞中所测试的。 GFPi分析还成功地对各种RSS对的RE进行了排序,包括与V(D)J片段相关的真正的RSS,在已知影响其效率的特定核苷酸处修饰或不修饰的人工共有序列,或涉及RAG依赖性激活的隐秘RSS癌基因。我们的工作验证了GFPi报告基因是研究RAG活性和RSS效率的实用定量工具。它对研究RAG介导的V(D)J和异常重排,谱系定型以及脊椎动物进化将是有用的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号